Multimarker analysis of childhood acute lymphoblastic leukemia (ALL): heterogeneity of cellular phenotypes and clinical relevance of immunological defined ALL subclasses

I Thoene et al. Haematol Blood Transfus. 1983.

. 1983:28:126-30.

doi: 10.1007/978-3-642-68761-7_28.

No abstract available

Similar articles

Definition of the high-risk acute lymphoblastic leukemia patient by immunological phenotyping with monoclonal antibodies.
Zipf TF, Fox RI, Dilley J, Levy R. Zipf TF, et al. Cancer Res. 1981 Nov;41(11 Pt 2):4786-9. Cancer Res. 1981. PMID: 6975160
Immunological subclassification of non-T, non-B acute lymphoblastic leukaemia in childhood.
Komada Y, Azuma E, Tanaka S, Ochiai H, Sakurai M. Komada Y, et al. Scand J Haematol. 1986 Jan;36(1):85-91. doi: 10.1111/j.1600-0609.1986.tb02655.x. Scand J Haematol. 1986. PMID: 2937137
Quantitative variation of the common acute lymphoblastic leukemia antigen (gp100) on leukemic marrow blasts.
Look AT, Melvin SL, Brown LK, Dockter ME, Roberson PK, Murphy SB. Look AT, et al. J Clin Invest. 1984 Jun;73(6):1617-28. doi: 10.1172/JCI111368. J Clin Invest. 1984. PMID: 6233301 Free PMC article.
Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia.
Greaves MF. Greaves MF. Cancer Res. 1981 Nov;41(11 Pt 2):4752-66. Cancer Res. 1981. PMID: 7028250 Review.
Biological and clinical significance of immunological cell markers in leukemia.
Thiel E. Thiel E. Recent Results Cancer Res. 1984;93:102-58. doi: 10.1007/978-3-642-82249-0_5. Recent Results Cancer Res. 1984. PMID: 6382477 Review. No abstract available.